New York, NY
Summary
This business focuses on the development of RNA therapeutics using advanced technologies such as Artificial Intelligence and Machine Learning. Their proprietary SpliceCore® software platform enhances the discovery of drug targets by analyzing RNA sequencing data, allowing for faster and more precise identification of therapeutic targets. The platform is particularly adept at detecting splicing variations, which are critical for developing effective RNA-based therapies. Additionally, they have a specialized branch, SpliceIO™, that targets tumor-specific neoepitopes for immunotherapy applications.
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Parked
false
Blocked
false
SIC Code
8731
Industry
Biotechnology and Pharmaceutical Development
Language
en
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
No Content?
false
Website Type
business
businessName
Envisagenics
Phone Numbers
Email Addresses
Business Summary
This business focuses on the development of RNA therapeutics using advanced technologies such as Artificial Intelligence and Machine Learning. Their proprietary SpliceCore® software platform enhances the discovery of drug targets by analyzing RNA sequencing data, allowing for faster and more precise identification of therapeutic targets. The platform is particularly adept at detecting splicing variations, which are critical for developing effective RNA-based therapies. Additionally, they have a specialized branch, SpliceIO™, that targets tumor-specific neoepitopes for immunotherapy applications.
Business Location
New York, NY
Industry Keywords
RNA therapeutics, biotechnology, drug discovery, artificial intelligence, machine learning
Business Entity Name
Envisagenics, Inc.
similarWebsiteUrls
[]
Business Location Country
US